615 drugs under control regime, more steps in offing: Govt

Image
Press Trust of India New Delhi
Last Updated : Dec 18 2014 | 3:10 PM IST
Informing that 615 essential drugs have been brought under price control mechanism, government today told the Lok Sabha that the costs of medicines have reduced over the last six months and more steps are in the offing to check prices.
Government said that by next month, it will come out with a new list of life-saving drugs whose prices would be controlled.
Chemicals and Fertilisers Minister Ananth Kumar said since the new government came to power in May, 175 essential drugs have been added to the list of drugs which are under price control mechanism, taking the number to 615 as 440 were already covered under it.
New steps are being planned to check prices and increase availability of generic drugs, he said replying to a Calling Attention Motion.
In the motion, Congress members Ranjeet Ranjan and Susmita Dev accused the government of allowing substantial hike in essential drug prices, including those used for treating cancer, heart ailments, HIV and diabetes.
They attacked the government for the botched up sterlisation cases in Chhattisgarh which had claimed 17 lives recently, saying rise in drug prices as well as easy availability of spurious medicines were the major reasons for this.
To this, Health Minister J P Nadda promised stringent action to prevent such incidents in the future.
"(Medical) camps are not target-oriented but demand driven ... (Following the Chhattisgarh incident) we have issued advisories and are reviewing their functioning to make such camps more effective," he said.
While Kumar said 3,000 outlets to sell generic drugs would be opened across the country, Nadda said the government would come out by January with a new list of life-saving drugs whose prices would be controlled.
"In the last six months, the price of no drug or medicine has been hiked" and there is no question of prices skyrocketing, Kumar said, terming it as "misinformation campaign".
"The aim of the government is to ensure good quality and affordable medicines for people," he noted.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 18 2014 | 3:10 PM IST

Next Story